Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 5/2006

01-05-2006 | Original Paper

Heparin and Insulin in the Treatment of Hypertriglyceridemia-Induced Severe Acute Pancreatitis

Authors: Hakan Alagözlü, Mehmet Cindoruk, Tarkan Karakan, Selahattin Ünal

Published in: Digestive Diseases and Sciences | Issue 5/2006

Login to get access

Excerpt

Acute pancreatitis (AP) has been defined as the presence of a consistent clinical history and physical examination supported by serum amylase elevated to at least three times the upper limit of normal and positive pancreatic imaging. Severe pancreatitis has been defined as an APACHE II score ≥8 or a Ranson score ≥2 [1]. …
Literature
1.
Toouli J, Brooke-Smith M, Bassi C, et al. (2002) Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol 17 (Suppl):15–39CrossRef
2.
Fortson MR, Freedman SN, Webster PD 3rd (1995) Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 90:2134–2139PubMed
3.
Yadav D, Pitchumoni CS (2003) Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol 36:54–62PubMedCrossRef
4.
Henzen C, Rock M, Schnieper C, Heer K (1999) Heparin and insulin in the treatment of acute hypertriglyceridemia-induced pancreatitis. Schweiz Med Wochenschr 129:1242–1248PubMed
5.
Jabbar MA, Zuhri-Yafi MI, Larrea J (1998) Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia. J Am Coll Nutr 17:458–461PubMed
6.
Sakorafas GH, Tsiotou AG (2000) Etiology and pathogenesis of acute pancreatitis: current concepts. J Clin Gastroenterol 30(4):343–356PubMedCrossRef
7.
Piolot A, Nadler F, Cavallero E, et al. (1996) Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas 13:96–99PubMedCrossRef
8.
Dominguez-Munoz JE, Malfertheiner P, Ditschuneit HH, et al. (1991) Hyperlipidemia in acute pancreatitis: relationship with etiology, onset, and severity of the disease. Int J Pancreatol 10:261–267PubMed
9.
Fallat RW, Vester JW, Glueck CJ (1973) Suppression of amylase activity by hypertriglyceridemia. JAMA 225:1331–1334PubMedCrossRef
10.
Toskes PP (1990) Hyperlipidemic pancreatitis. Gastroenterol Clin North Am 19:783–791PubMed
11.
Berger Z, Quera R, Poniachik J, et al. (2001) Heparin and insulin treatment of acute pancreatitis caused by hypertriglyceridemia. Experience of five cases. Rev Med Chil 129:1373–1378PubMed
12.
Lennertz A, Parhofer KG, Samtleben W, Bosch T (1999) Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis. Ther Apher 3:227–233PubMedCrossRef
13.
Routy JP, Smith GH, Blank DW, Gilfix BM (2001) Plasmapheresis in the treatment of an acute pancreatitis due to protease inhibitor induced hypertriglyceridemia. J Clin Apheresis 16:157–159PubMedCrossRef
Metadata
Title
Heparin and Insulin in the Treatment of Hypertriglyceridemia-Induced Severe Acute Pancreatitis
Authors
Hakan Alagözlü
Mehmet Cindoruk
Tarkan Karakan
Selahattin Ünal
Publication date
01-05-2006
Published in
Digestive Diseases and Sciences / Issue 5/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-005-9006-z

Other articles of this Issue 5/2006

Digestive Diseases and Sciences 5/2006 Go to the issue

Report

Depressed-Type Early Invasive Colon Cancer in a Patient Treated with Cyclooxygenase-2 Inhibitor

OriginalPaper

Celiac Disease Prevalence in Brazilian Dilated Cardiomyopathy Patients

ORIGINAL PAPER

Gastric H,K-ATPase as a Drug Target

Original Paper

Presenting Symptoms of Nonerosive and Erosive Esophagitis in Pediatric Patients

OriginalPaper

Prevalence and Demographic Characteristics of Celiac Disease Among Blood Donors in Ribeirão Preto, State of São Paulo, Brazil

Letter To The Editor

Acid Perfusion Test: A Useful Test for Evaluating Esophageal Acid Sensitivity?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits